7 June 2000 Preliminary results of tracked laser-assisted in-situ keratomileusis (T-LASIK) for myopia and hyperopia using the autonomous technologies excimer laser system
Author Affiliations +
Proceedings Volume 3908, Ophthalmic Technologies X; (2000) https://doi.org/10.1117/12.387521
Event: BiOS 2000 The International Symposium on Biomedical Optics, 2000, San Jose, CA, United States
Abstract
A study was undertaken to assess the safety and efficacy of LASIK with the LADARVision laser by Autonomous Technologies, (Orlando, FL). The study included four subsets: Spherical myopia -- up to -11.00D, spherical hyperopia -- up to +6.00D. Both myopic and hyperopic astigmatism could be corrected, up to 6.00D of astigmatism. A total of 105 patients participated. Sixty-six patients were myopic and 39 were hyperopic. The mean (+/- SD) age was 42.8 +/- 9.3 years for myopia and 53.2 +/- 9.9 years for hyperopia. At 3 months postop. Sixty-one myopic eyes were available for evaluation. Uncorrected visual acuity was 20/20 in 70% of eyes and 20/40 in 92.9% of all eyes. The refractive outcome was within +/- 0.50D in 73.8% of eyes and within +/- 1.00D in 96.7 of eyes. Thirty-eight hyperopic eyes were available. Uncorrected visual acuity was 20/20 in 42.1% of eyes and 20/40 in 88% of all eyes. The refractive outcome was within +/- 0.50D in 57.9% of eyes and within +/- 1.00D in 86.8% of eyes. Complications were not sight threatening and were discussed in detail. Lasik with the LADARVision laser appears to be safe and effective.
© (2000) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Ezra I. Maguen, Ezra I. Maguen, Anthony B. Nesburn, Anthony B. Nesburn, James J. Salz, James J. Salz, } "Preliminary results of tracked laser-assisted in-situ keratomileusis (T-LASIK) for myopia and hyperopia using the autonomous technologies excimer laser system", Proc. SPIE 3908, Ophthalmic Technologies X, (7 June 2000); doi: 10.1117/12.387521; https://doi.org/10.1117/12.387521
PROCEEDINGS
7 PAGES


SHARE
Back to Top